Search clinical trials for: BI 730357 (Reference)

Total 2131 results

Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

Healthy

Netherlands
Boehringer Ingelheim

Terminated

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

Psoriasis

United States, Canada, Germany
Boehringer Ingelheim

Withdrawn

A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis

Arthritis, Psoriatic
Boehringer Ingelheim

Completed

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated

Healthy

Japan
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 730357 is Processed by the Body

Healthy

Netherlands
Boehringer Ingelheim

Completed

This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers

Healthy Volunteers

Germany
Boehringer Ingelheim

Completed

Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects

Healthy

Germany
Boehringer Ingelheim

Terminated

A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body

Healthy

United Kingdom
Boehringer Ingelheim

Completed

Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

Healthy

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions

Healthy

Germany
Chong Kun Dang Pharmaceutical

Completed

A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects

Hypertension | Dyslipidemias

Korea, Republic of
OsciFlex LLC
University of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluation of the OsciPulse Rapid Cycling Compression Device Effects on Venous Blood Flow

Venous Stasis | Venous Thromboses

United States
Dong-A Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Infertility | Induction of Ovulation
The Affiliated Hospital of Qingdao University

Enrolling by invitation

Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects

Pharmacokinetics | Safety

China
Academisch Medisch Centrum - Universiteit van Amsterdam...
DexCom, Inc.

Completed

Factors in Accuracy Studies Influencing Measured CGM Performance. (FACT-CGM)

Diabetes Mellitus, Type 1

Netherlands
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Equivalence Study of Specificity of PPD (03)

Tuberculosis Infection

United States
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Recruiting

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)

Netherlands
Nutricia Research

Recruiting

Assessment of the Glycemic Responses to Nutritional Products (v2.0) (GLIN#2)

Glycemic Response

Canada
UCSF Benioff Children's Hospital Oakland
Almond Board of California

Completed

Effects of Almond Intake on Atherogenic Lipoprotein Particles

Dyslipidemia | Obesity, Abdominal

United States
Boehringer Ingelheim

Withdrawn

A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Anal Canal Squamous Cell Carcinoma

Korea, Republic of
Sonova AG

Completed

Pre-calculation for Frequency Lowering With Hearing Devices

Frequency Lowering

Switzerland
Boehringer Ingelheim

Not yet recruiting

A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity

Obesity
Boehringer Ingelheim

Active, not recruiting

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

Solid Tumors

Hungary
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

Healthy

Netherlands
Asir John Samuel
Maharishi Markandeshwar International School, Mullana

Completed

Normative Reference Values of Equilibrium Coordination Test Among Children

Coordination Disorder, Developmental

India
Institut fur Diabetes Karlsburg GmbH

Completed

User Evaluation of BGM VGM77

Diabetes

Germany
National Research Centre for the Working Environment...
University of Southampton

Completed

Implementation of Physical Exercise at the Workplace (IRMA10) - Occupational Load (IRMA10)

Stress | Musculoskeletal Disorders

Denmark
National Research Centre for the Working Environment...
University of Southern Denmark

Completed

Work Place Adjusted Intelligent Physical Exercise Reducing Musculoskeletal Pain in Shoulder and Neck (VIMS) - Shoulder Function (VIMS03)

Neck Pain | Shoulder Pain | Rehabilitation | Scapular Dyskinesis | Muscle Activation

Denmark
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

Healthy | Asthma

Germany
Fundación Cardiovascular de Colombia

Completed

Continuous Supraglottic Aspiration in Intubated and Mechanically Ventilated Patients: the "SUPRAtube" Device (Supratube)

Aspiration Pneumonias

Colombia
National Research Centre for the Working Environment...
University of Southampton; University of Southern Denmark

Completed

Implementation of Physical Exercise at the Workplace (IRMA09) - Laboratory Technicians (IRMA)

Stress | Musculoskeletal Disorders

Denmark
Almirall, S.A.
Sciderm GmbH

Completed

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Psoriasis

Germany
Boehringer Ingelheim

Completed

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Neoplasms | Carcinoma, Non-Small-Cell Lung

United States, Spain, United Kingdom, Canada, Poland
Boehringer Ingelheim

Terminated

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

Neoplasms | Carcinoma, Non-Small-Cell Lung | Neoplasm Metastasis

United States
Boehringer Ingelheim

Completed

Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.

Healthy

Germany
Clinical Nutrition Research Centre, Singapore
Barilla Singapore Pte Ltd

Completed

Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian Foods

Diabetes

Singapore
Boehringer Ingelheim

Completed

A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Solid Tumors, KRAS Mutation

Japan
Boehringer Ingelheim

Completed

A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors)

Solid Tumors

Japan
Boehringer Ingelheim

Completed

Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

Asthma

Germany
JW Pharmaceutical

Completed

To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers

Healthy

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Recruiting

Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Event of Worsening Health Status? (ESOP)

Neoplasm Metastasis | Advanced Cancer | Locoregional Neoplasm

France
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

Healthy

Germany
Boehringer Ingelheim

Recruiting

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack (IRI-EXPLORE)

Myocardial Infarction

Korea, Republic of, Germany, Spain, United Kingdom, Hungary, Italy, Canada, Australia, Poland, Slovakia, New Zealand
Boehringer Ingelheim

Recruiting

A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer

Neuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)

Netherlands

3

Subscribe